Akebia Therapeutics | Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Acadia Pharmaceuticals USD 917.27M 94.89M 2025-09
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Ardelyx USD 154.28M 14.75M 2025-09
Astellas Pharma JPY 1.76T 150.69B 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Bayer EUR 29.7B 799M 2025-09
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Celltrion KRW 16.7T 182.36B 2025-09
Cspc Pharmaceutical CNY 33.25B 984.93M 2025-06
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 546.45M 243.38M 2025-09
Exelixis USD 2.16B 619K 2025-12
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Ironwood Pharmaceuticals USD -264.16M 44M 2025-09
J&J USD 78.47B 0 2025-09
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Lexicon Pharmaceuticals USD 129.44M 6.41M 2025-06
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 349.13M 36.37M 2025-09
Ovoca Bio EUR 8.67M 4.76M 2022-06
Pharma Mar EUR 251.83M 54.32M 2025-12
Prothena USD 294.99M 29.34M 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 1.55B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 267.53M 16.24M 2025-09
Tilray USD 1.51B 1.22B 2025-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09


Akebia Therapeutics Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.